CFDE Data Portal | Search RPL39P16

	Label	Description
	RPL39P16 Gene (Entity type)	ENSG00000227470 - ribosomal protein L39 pseudogene 16
	GSE136414 hydroxyl 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 0 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 7 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE135686 etomoxir macrophage 2 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 11 v 12 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE186280 sorafenib 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE117620 resveratrol 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS

RPL39P16

ENSG00000227470 - ribosomal protein L39 pseudogene 16

GSE136414 hydroxyl 1 v 2 human dn

A Gene Set from LINCS

GSE100148 EZH2 inhibition 0 v 5 human up

A Gene Set from LINCS

GSE239844 crizotinib 7 v 5 human up

A Gene Set from LINCS

GSE135686 etomoxir macrophage 2 v 3 human dn

A Gene Set from LINCS

GSE239844 crizotinib 11 v 12 human dn

A Gene Set from LINCS

GSE186280 sorafenib 1 v 0 human dn

A Gene Set from LINCS

GSE117620 resveratrol 1 v 3 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.